| Name | Sales (Cr) | Profit (Cr) | EBITDA (Cr) | Financial Year |
|---|---|---|---|---|
| CARE Ratings | 331.68 | 102.56 | 158.82 | MAR, 2024 |
| CRISIL | 3,139.52 | 658.44 | 975.14 | DEC, 2023 |
| ICRA | 403.23 | 136.73 | 192.46 | MAR, 2023 |
| Company | Market Cap (Cr) | Chg (%) | PE (x) | PB (x) | EV to Sales (x) | EV to EBITDA (x) | Dividend Yield (%) |
|---|---|---|---|---|---|---|---|
| CRISIL | 31,096.28 | 4.47 | 47.81 | 14.20 | 9.80 | 34.36 | 1.27 |
| ICRA | 5,635.60 | 1.76 | 37.30 | 5.77 | 13.40 | 38.58 | 1.71 |
| CARE Ratings | 3,182.23 | 1.21 | 31.65 | 4.43 | 9.46 | 28.23 | 1.69 |
Invest
